Respiratory Disease Soaring in Newborns

COVID-associated respiratory distress diagnoses increased by 1150% within a year, when vaccines were recommended to pregnant women.

COVID-Associated Acute Respiratory Distress in Newborns

I’ve found yet another unsettling safety signal in my German hospital dataset.

As soon as the vaccine commission recommended pregnant women in the 2nd and 3rd trimester to get vaccinated, the number of newborns suffering U07.1-associated respiratory distress rose steeply.

• Between September 2020 and August 2021, the average hospitalization rate of neonates diagnosed with both U07.1 and J96.00 was 3.17 per month.

• Between September 2021 and August 2022, the average hospitalization rate of neonates diagnosed with both U07.1 and J96.00 was 39.75 per month.

These figures show an increase of more than 1150% from one year to the next. Yet maternal vaccinations had been promoted for protecting infants from falling ill with COVID-19.

COVID burden was almost negligible for infants in 2020 and early 2021, but it was well known that the shots provided little protection against Delta variants which had already gained full predominance over previous strains by September 2021. Here is the “scientific” rationale behind the STIKO’s decision (German PDF).

It gets worse!

As of today (January 20, 2024) the German RKI is still recommending these vaccines to pregnant women, but worst of all:

The STIKO is recommending Biontech/Pfizer products as the ideal candidate for pregnant women - in fact they are explicitely discouraging use of Moderna products during pregnancy!

According to the STIKO, Spikevax products should generally not be used in pregnant women.

(Emphasis not mine)

I copied this from the RKI homepage today, long after it had become common knowledge, that most Pfizer/Biontech batches are contaminated with DNA. Why is that an issue? Well, the younger a human organism is, the more frequently its cells divide (the embryo’s relative growth rate peaks 20 days post-conception).

Cell division is prone to errors. Cells that divide are at a particularly high risk to integrate foreign DNA, which would then end up in the daughter cells. This DNA can in turn be transferred to the next generation of cells the next time the daughter cells divide.

Linear DNAs, including those derived from cleavage of circular DNAs after entering a cell, may undergo non-homologous end joining (NHEJ) to be randomly integrated into the host cell genome, while being prone to exonuclease digestion.

Source: https://www.nature.com/articles/s41598-023-33862-0

Now you are probably wondering what exonucleases are. Exonucleases are enzymes that cut nucleic acids off DNA/RNA and are highly active during DNA replication, which is precisely what needs to happen for a cell to divide.

Timing of vaccination

The details of the recommendation are quite interesting (German Source).

Unvaccinated pregnant women are recommended to build up basic immunity. It is important for basic immunity that the immune system has three contacts with components of the pathogen (vaccination) or the pathogen itself (infection). At least one of these contacts should be through the vaccination.

Furthermore, RKI states the following:

Pregnant women should only be vaccinated from the 2nd trimester onwards.

However…

According to the STIKO [...] the 3rd vaccination to achieve basic immunity should be given at least 6 months after the 2nd vaccination in order to achieve optimum protection.

This can only result in a large proportion of pregnant women receiving a dose shortly before giving birth, which might be the reason we are seeing signs of Vaccine-Mediated Enhanced Disease (VMED) in these newborns.

Ask Why 429 Moms Died

EDIT

Since posting this article a few individuals have pointed out to me that COVID incidence increased around the same time hospitalizations of newborns with J96.00 and U07.1 increased.

Here you are seeing the monthly proportion of infants (age 28d - <1 year) among all children hospitalized with a diagnosis of U07.1. The signal is still present.